| Dr Brian Etheridge, MD | |
|
1007 N Pope St, Silver City, NM 88061-5161 | |
| (575) 388-1511 | |
| (575) 313-8236 |
| Full Name | Dr Brian Etheridge |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 1007 N Pope St, Silver City, New Mexico |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487767562 | NPI | - | NPPES |
| 40906361 | Medicaid | NM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | MD2007-0195 (New Mexico) | Primary |
| Entity Name | Hidalgo Medical Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306843180 PECOS PAC ID: 4587572250 Enrollment ID: O20040303001246 |
News Archive
Early on in the pandemic, it was thought that the virus was only spread via respiratory droplets. However, scientific research soon showed it also to be an airborne virus. Now, the U.S. Centers for Disease Control and Prevention (CDC) has updated its guideline, acknowledging that the virus can hang in the air, fueling its spread.
A new study published on the preprint server bioRxiv* in August 2020 reports the use of prediction and advanced simulation techniques to identify a novel T cell epitope on the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that could serve as the basis for a customized vaccine with broad-based efficacy.
Hotspur Technologies, Inc. announced today that it has received FDA clearance for the first three commercial products in its portfolio. These products are based on Hotspur's unique and groundbreaking technology that makes dialysis access interventional and peripheral vascular procedures that open blood vessels less expensive, more efficient, and less invasive for patients.
By many estimates, an Ebola vaccine could be available in humans as early as next year. But will it be the right one? There are a number of vaccines in development and each is in a race to prove that it is most effective, safe and that it will protect the largest number of people.
In a new study, appearing on the pre-print server medRxiv*, researchers at the University of Trieste and Istituto Auxologico Italiano IRCCS in Italy report that more than half of patients with previous mild-to-moderate symptomatic COVID-19 complained of the persistence of at least one symptom 12-months after the onset of the illness.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brian Etheridge, MD 530 De Moss St, Lordsburg, NM 88045-2618 Ph: (575) 542-2307 | Dr Brian Etheridge, MD 1007 N Pope St, Silver City, NM 88061-5161 Ph: (575) 388-1511 |
News Archive
Early on in the pandemic, it was thought that the virus was only spread via respiratory droplets. However, scientific research soon showed it also to be an airborne virus. Now, the U.S. Centers for Disease Control and Prevention (CDC) has updated its guideline, acknowledging that the virus can hang in the air, fueling its spread.
A new study published on the preprint server bioRxiv* in August 2020 reports the use of prediction and advanced simulation techniques to identify a novel T cell epitope on the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that could serve as the basis for a customized vaccine with broad-based efficacy.
Hotspur Technologies, Inc. announced today that it has received FDA clearance for the first three commercial products in its portfolio. These products are based on Hotspur's unique and groundbreaking technology that makes dialysis access interventional and peripheral vascular procedures that open blood vessels less expensive, more efficient, and less invasive for patients.
By many estimates, an Ebola vaccine could be available in humans as early as next year. But will it be the right one? There are a number of vaccines in development and each is in a race to prove that it is most effective, safe and that it will protect the largest number of people.
In a new study, appearing on the pre-print server medRxiv*, researchers at the University of Trieste and Istituto Auxologico Italiano IRCCS in Italy report that more than half of patients with previous mild-to-moderate symptomatic COVID-19 complained of the persistence of at least one symptom 12-months after the onset of the illness.
› Verified 7 days ago
Donald F. Johnson, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 114 W 11th St, Hms Med Square, Silver City, NM 88061 Phone: 575-388-1511 Fax: 575-388-3465 | |
Sam W Lew, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1600 E 32nd St, Silver City, NM 88061 Phone: 575-538-2981 Fax: 855-653-5171 | |
Dr. Raymer William Seavers, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1302 E 32nd St, Va Community Clinic, Silver City, NM 88061 Phone: 505-538-2921 Fax: 505-388-9260 | |
Dr. Lindsay Andre Worrell, M.B. B.S. FAAP Pediatrics Medicare: Medicare Enrolled Practice Location: 1313 E 32nd St, Silver City, NM 88061 Phone: 575-956-5909 | |
Barbara James Mora, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1600 E 32nd St, Silver City, NM 88061 Phone: 575-538-2981 Fax: 575-388-3373 | |
Dr. Vladimir Spira, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 114 W 11th St, Silver City, NM 88061 Phone: 575-388-1511 Fax: 575-388-3465 |